The σ(1) receptor antagonist S1RA is a promising candidate for the treatment of neurogenic pain

J Med Chem. 2012 Oct 11;55(19):8209-10. doi: 10.1021/jm3011993. Epub 2012 Sep 5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Female
  • Humans
  • Male
  • Morpholines / chemical synthesis*
  • Pyrazoles / chemical synthesis*
  • Receptors, sigma / antagonists & inhibitors*
  • Sigma-1 Receptor

Substances

  • 4-(2-((5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine
  • Morpholines
  • Pyrazoles
  • Receptors, sigma